WallStreetZenWallStreetZen

NASDAQ: NVCT
Nuvectis Pharma Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for NVCT

Based on 1 analyst offering 12 month price targets for Nuvectis Pharma Inc.
Min Forecast
$21.00+17.85%
Avg Forecast
$21.00+17.85%
Max Forecast
$21.00+17.85%

Should I buy or sell NVCT stock?

Based on 1 analyst offering ratings for Nuvectis Pharma Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NVCT stock forecasts and price targets.

NVCT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 12%
89
BuyReiterates$21.00+17.85%2023-03-07

1 of 1

Forecast return on equity

Is NVCT forecast to generate an efficient return?
Company
-189.11%
Industry
29.69%
Market
89.37%
NVCT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NVCT forecast to generate an efficient return on assets?
Company
-143.21%
Industry
11.82%
NVCT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NVCT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NVCT$17.82$21.00+17.85%Buy
IMRX$9.90$18.67+88.56%Strong Buy
NGM$3.41$6.50+90.62%Strong Buy
ATAI$1.75$13.50+671.43%Strong Buy
RIGL$1.61$6.67+314.10%Buy
View Top Biotech Stocks

Nuvectis Pharma Stock Forecast FAQ

Is Nuvectis Pharma Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NVCT) stock is to Buy NVCT stock.

Out of 1 analyst, 0 (0%) are recommending NVCT as a Strong Buy, 1 (100%) are recommending NVCT as a Buy, 0 (0%) are recommending NVCT as a Hold, 0 (0%) are recommending NVCT as a Sell, and 0 (0%) are recommending NVCT as a Strong Sell.

If you're new to stock investing, here's how to buy Nuvectis Pharma stock.

What is NVCT's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: NVCT) forecast ROE is -189.11%, which is considered weak.

What is NVCT's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NVCT price target, the average NVCT price target is $21.00, with the highest NVCT stock price forecast at $21.00 and the lowest NVCT stock price forecast at $21.00.

The Wall Street analyst predicted that Nuvectis Pharma's share price could reach $21.00 by Mar 7, 2024. The average Nuvectis Pharma stock price prediction forecasts a potential upside of 17.85% from the current NVCT share price of $17.82.

What is NVCT's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: NVCT) forecast ROA is -143.21%, which is lower than the forecast US Biotechnology industry average of 11.82%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.